NIH – Countermeasures Against Chemical Threats (CounterACT; two funding opportunities)

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
(PAR-19-039)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt/Submission Date(s): September 10, 2019; September 9, 2020; September 14, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
(PAR-19-040)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt/Submission Date(s): September 10, 2019; September 9, 2020; September 14, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.